Spatial and Temporal Heterogeneity in Clonal Evolution of Nonsmall-cell Lung Cancer: Implications for Therapy Cover

.blurhash-client-img { display: none !important; }

Spatial and Temporal Heterogeneity in Clonal Evolution of Nonsmall-cell Lung Cancer: Implications for Therapy

Forum of Clinical Oncology

Volume 13 (2022): Issue 3 (December 2022)

By: A. Koulouris, C. Tsagkaris and G. Mountzios

Open Access

|Oct 2023

Authors

A. Koulouris

andreas.koulouris@gmail.com

Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden

Thoracic Oncology Center, Karolinska University Hospital, Stockholm, Sweden

University of Crete, Faculty of Medicine, Heraklion, Greece

C. Tsagkaris

European Student Think Tank, Public Health and Policy Working Group, Amsterdam, Netherlands

G. Mountzios

Department of Medical Oncology, 251 General Airforce Hospital, Athens, Greece

DOI: https://doi.org/10.2478/fco-2023-0005 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X

Journal RSS Feed

Language: English

Page range: 3 - 14

Submitted on: Jun 20, 2023

|

Accepted on: Jul 25, 2023

|

Published on: Oct 12, 2023

Published by: Helenic Society of Medical Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Nonsmall-cell lung cancer,

targeted treatment

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology

© 2023 A. Koulouris, C. Tsagkaris, G. Mountzios, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 13 (2022): Issue 3 (December 2022)Next article